What Roles Can NPs and PAs Play in a Practice? Part 1
The team approach allows for more eyes on the patient, so more information can be gathered to help pinpoint any barriers to care.
Interesting Endo: Fracture Risk & Endocrine Disruptors
Our April list includes predictors of fracture risk, endocrine-disrupting chemicals, and CV effects of thyroid dysfunction.
Adjuvant Metformin in Type 1 Diabetes
This study is the first retrospective, long-term analysis of metformin as adjuvant therapy to insulin in patients with T1DM.
Renal Effects: SGLT2 Inhibitors in Type 2 Diabetes
A meta-analysis compared the renal side effects of SGLT2 inhibitors in patients with type 2 diabetes.
Fructosamine: a Potentially Useful Surrogate
Under what circumstances may fructosamine levels be useful in monitoring glucose control?
Screen Time and Insulin Resistance in Children
The health effects of sedentary behavior, such as screen time, include adiposity & T2DM risk in adults. How does screen time affect children?
CV Events: Safety of Insulin
A study compared mortality and major adverse cardiovascular events in patients with type 2 diabetes prescribed metformin or insulin.
Interesting T2DM: Pharmacotherapy & Obesity Outcomes
Our April list includes CV events with DPP-4 or SGLT2 inhibitors vs. insulin, and impact of obesity on nonalcoholic fatty liver disease and thyroid function.
The Uninsured, Hospitalized Patient
When someone in the hospital needs to see a specialist, particularly a specialty where there are so few of us, I don’t understand how one can just refuse.
GLP-1 Agonists: Beneficial in Low-Risk Patients?
Do low-risk CVD patients with T2DM experience the same significantly lower all-cause and CV mortality seen in high-risk patients?
By clicking Accept, you agree to become a member of the UBM Medica Community.